Oberweis Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.5M Buy
512,100
+119,900
+31% +$10.2M 0.84% 33
2026
Q1
$33.8M Buy
392,200
+122,200
+45% +$11M 1% 19
2025
Q4
$23.6M Buy
+270,000
New +$20.5M 0.86% 35
2016
Q2
Sell
-15,200
Closed -$361K 174
2016
Q1
$361K Buy
15,200
+1,539
+11% +$37.6K 0.1% 142
2015
Q4
$380K Buy
+13,661
New +$343K 0.11% 143

Other funds holding GMED

Oberweis Asset Management's GMED Position: Q2 2026 in Review

Oberweis Asset Management increased its Globus Medical (GMED) stake by 31% in Q2 2026, buying an estimated $10.2M and bringing the position to 512,100 shares worth $40.5M. The position accounts for 0.84% of the portfolio, ranked #33.

Oberweis Asset Management first reported a position in GMED in Q4 2015 and has held it in 5 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Oberweis Asset Management held 512,100 shares of Globus Medical worth $40.5M as of Q2 2026.
  • Oberweis Asset Management bought 119,900 Globus Medical shares in Q2 2026, an estimated $10.2M.
  • Globus Medical made up 0.84% of Oberweis Asset Management's portfolio in Q2 2026, its #33 holding.
  • Oberweis Asset Management first reported a position in Globus Medical in Q4 2015 and has held it in 5 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.